|
News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days Check below for free stories on DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN the last two weeks. |
|
|
| May 22, 2013 |
| 18:52 EDT |  | MRK | On The Fly: After Hours Movers
UP AFTER EARNINGS: Hewlett-Packard (HPQ), up 13.4% after reporting second quarter earnings that beat expectations and guiding third quarter and full-year earnings above estimates... Pacific Sunwear (PSUN), up 14.3%. ALSO HIGHER: Merck (MRK), up 0.2% after an FDA advisory panel voted 13-3 in support of the safety of initial doses of its insomnia drug suvorexant. DOWN AFTER EARNINGS: DryShips (DRYS), down 4.7%. ALSO LOWER: Apricus Biosciences (APRI), down 11.5% after filing to sell an ungiven amount of stock... NCI Building Systems (NCS) after being replaced by Cynosure (CYNO) in the S&P 600 as of May 31. |
|
| 18:32 EDT | | MRK | Merck's suvorexant for insomnia reviewed by FDA advisory committee
 Subscribe for More Information |
|
| 18:06 EDT |  | MRK | Merck insomnia drug gets FDA panel backing, WSJ reports
Merck's insomnia drug suvorexant received a favorable 13-3 vote from an FDA panel on the drug's two proposed starting doses, with the panel splitting the vote on the safety of higher doses, reports the Wall Street Journal. Reference Link |
|
| 16:16 EDT | | MRK | FDA panel votes 13-3 that Merck insomnia drug safe in low doses, Bloomberg says
Subscribe for More Information |
|
| 16:00 EDT |  | MRK | Options Update; May 22, 2013
Subscribe for More Information |
|
| 14:52 EDT | | MRK | FDA panel says Merck insomnia drug effective as sleep aid, Bloomberg reports
Subscribe for More Information |
|
| 09:39 EDT | | MRK | Active equity option families trading
Subscribe for More Information |
|
| 07:45 EDT |  | MRK | FDA Peripheral & Central Nervous System Drugs Advisory Committee holds a meeting
Subscribe for More Information |
|
| 07:24 EDT | | DELL | NetEvents International to host a summit
Subscribe for More Information |
|
| May 21, 2013 |
| 18:56 EDT | | MRK | On The Fly: After Hours Movers
Subscribe for More Information |
| |
| 17:03 EDT | | MRK | Merck announces $5B share repurchase
Subscribe for More Information |
|
| 17:01 EDT | | MRK | Merck announces $5B accelerated share repurchase
Subscribe for More Information |
|
| 13:17 EDT | | NFLX | Netflix says Ricky Gervais' original series to debut September 12
Subscribe for More Information |
|
| 10:00 EDT |  | MAT | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:44 EDT | | MRK | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:07 EDT |  | ELN | Theravance pullback on Elan bid a buying opportunity, says Piper Jaffray
Subscribe for More Information |
|
| May 20, 2013 |
| 17:49 EDT | | MRK | Merck sleep drug effective, dosages questioned, WSJ reports
Subscribe for More Information |
|
| 16:55 EDT | | DELL | S&P lowers Dell ratings to 'BBB' from 'A-', remains on watch negative
Standard & Poor's Ratings Services lowered its corporate credit and senior unsecured debt ratings on Dell to 'BBB' from 'A-', and its commercial paper rating to 'A-2' from 'A-1'. All ratings remain on CreditWatch, where they were placed with negative implications on Feb. 5. The initial CreditWatch listing reflected S&P's assessment that the $24.4B going private transaction, which includes a substantial portion of debt financing, will materially degrade Dell's financial risk profile, which S&P currently view as modest. Although Carl Icahn submitted a non-binding alternative acquisition proposal, the Michael Dell and Silver Lake Partners LBO proposal remains the only transaction that has been approved by Dell's board of directors. S&P's review of the LBO transaction terms and the company's ownership, business and financial strategy may also result in a downward revision of its assessment of Dell's business risk profile. |
|
| 16:15 EDT | | MAT | Mattel initiated with an Overweight at Piper Jaffray
Subscribe for More Information |
|
| 13:03 EDT | | ELN | Elan advises holders to take no action related to Royalty offer
Subscribe for More Information |
| |
| 11:46 EDT | | ELN | Royalty Pharma ups offer for Elan to $12.50 per share in cash
Royalty Pharma announced that it raised its takeover offer for Elan to $12.50 per share in cash. The increased offer is fully financed, cash confirmed and not conditional on due diligence, the company added, while saying the $1.00 per share net cash right has been eliminated. Royalty Pharma added that it has reserved its right to waive down the acceptance threshold for the increased offer from 90% to 50% plus one Elan share. Reference Link |
|
| 11:43 EDT | | ELN | Elan rallies 3.6% to $12.10 after Royalty Pharm raises buyout offer
|
|
| 11:42 EDT | | ELN | Royalty Pharma raises offer for Elan to $12.50 per share in cash
Subscribe for More Information |
|
| 11:14 EDT | | DELL | Dell to deliver public cloud through partner ecosystem
Subscribe for More Information |
|
| 07:32 EDT | | MRK | Society for Information Display / IHS to host a conference
Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. |
|
| 07:03 EDT | | DELL | Dell committee says cannot evaluate Icahn proposal without more information
Subscribe for More Information |
|
| 05:54 EDT | | ELN | Elan announces transactions to transform company, $200M share repurchase plan
Elan announces a series of transactions designed to decisively transform and advance the company. Upon shareholder approval, the totality of these strategically driven decisions, in addition to the Theravance royalty participation agreement and dividend pass through announced last week and the previously completed Tysabri transaction, will form a dynamic and unique business foundation for Elan in the years ahead. Elan will acquire 100% of AOP Orphan Pharmaceuticals and upon close Elan will pay EUR 263.5M for the company, comprised of EUR 175.7M in cash and EUR 87.8M of Elan ordinary shares. In addition, there will be potential cash milestone payments of up to EUR 270M on the advancement of certain late stage clinical programs. Elan has completed the first step in its investment in Newbridge by paying $40M in exchange for 48% of the total fully diluted capitalization of the company. In addition, Elan has appointed two directors to the board of Newbridge. Elan has the option to purchase the remaining stake in Newbridge by 2015 for a sum of $244M. Elan will commit $70M to the new entity upfront, plus up to a potential future $8M, for an 18% minority equity position, royalties in major markets along with additional milestones, and retention of commercial rights in certain territories and markets. The third party equity financial partner will commit $20M for 62% equity position, plus up to a potential future $2M. The remaining 20% equity will be allocated among Speranza management. This allows Elan to eliminate the operating activities associated with the development of the drug, while at the same time maintaining a share of the potential upside. A $200M share repurchse program is planned, details pending. |
|
| 05:22 EDT | | ELN | Elan to host business news update conference call
Subscribe for More Information |
|
| May 17, 2013 |
| 14:03 EDT |  | DELL | Market set to finish week with gains after Cisco results, comments
Subscribe for More Information |
|
| 10:18 EDT | | GDOT | Barclays' IT consulting & computer services analyst holds conference call
Subscribe for More Information |
| |
| 10:07 EDT |  | CTRP | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:37 EDT | | NFLX | Active equity option families trading on open
Subscribe for More Information |
|
| 08:29 EDT | | DELL | JPMorgan's business and information services analyst holds a conference call
Subscribe for More Information |
|
| 08:02 EDT | | DELL | Dell results could increase votes for Silver Lake offer, says Wells Fargo
Subscribe for More Information |
|
| 05:33 EDT | | CTRP | Ctrip.com upgraded to Neutral from Sell at Citigroup
Subscribe for More Information |
|
| May 16, 2013 |
| 18:01 EDT | | DELL | Dell continues to expect 'relatively weak' demand in end-user PC business
Subscribe for More Information |
|
| 16:05 EDT |  | DELL | Dell reports Q1 enterprise solutions, services, software revenue up 12% to $5.5B
Subscribe for More Information |
|
| 16:02 EDT | | DELL | Dell not providing guidance for Q2
Subscribe for More Information |
|
| 16:01 EDT | | DELL | Dell reports Q1 adjusted EPS 21c, consensus 35c
Reports Q1 revenue $14.1B, consensus $13.52B. |
|
| 15:14 EDT | | DELL | Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Dell (DELL), consensus 35c; Applied Materials (AMAT), consensus 13c; Nordstrom (JWN), consensus 76c; Autodesk (ADSK), consensus 45c; J. C. Penney (JCP), consensus (86c); SINA (SINA), consensus (3c); ViaSat (VSAT), consensus 2c; Brocade Communications (BRCD), consensus 15c; Aruba Networks (ARUN), consensus 15c. |
| |
| 13:58 EDT | | DELL | Earnings Preview: Dell facing uncertainty about going private ahead of Q1 report
Dell (DELL) is set to report Q1 earnings after the market close on Thursday, May 16, with a conference call scheduled for 4:45 pm ET. Dell is a global IT company that operates enterprise, business, and consumer segments. EXPECTATIONS: Analysts are looking for EPS of 35c on revenue of $13.52B, according to First Call. The consensus range for EPS is 28c-42c on revenue of $12.6B-$14.22B. A report by Dow Jones earlier this week said Dell will report non-GAAP EPS of 20c on revenue of about $14B. LAST QUARTER: Dell reported Q4 adjusted EPS of 40c against consensus for 39c on revenue of $14.3B against estimates for $14.12B. On its Q4 earnings conference call, the company said it expects continued margin pressure and market competitiveness in 2013. GO-PRIVATE NEWS: On February 5, Dell officially announced that it had agreed to be taken private for $13.65 per share by a consortium lead by Silver Lake. On March 25, Dell announced it had received two alternative proposals during its go-shop process, which began following its February 5 announcement. These proposals included a $14.25 per share offer from Blackstone (BX), and a $15 per share offer from Carl Icahn and affiliated funds, including Icahn Enterprises (IEP). On April 19, Dell announced that Blackstone decided not to submit a bid for the company. Last Friday, Icahn and Southeastern Asset Management, which collectively hold about a 13% stake in Dell, submitted an alternative proposal to Dell's board. The Icahn and Southeastern proposal would allow Dell shareholders to receive a $12 per share cash distribution or $12 of additional shares valued at $1.65 per share. On Monday, the special committee of Dell's board asked Icahn and Southeastern for more information related to proposal, while Icahn and Southeastern proposed a slate of directors to the company's board that same day. COMPANY NEWS: In addition to news surrounding the company's go-private proposal, data regarding global PC demand has also weighed on Dell. On April 10, data from IDC said worldwide PC shipments totaled 76.3M in Q1, a 13.9% decline from the prior year period, which was worse than the expected decline of 7.7%. IDC also added that this year-over-year decline was the worst since the firm began its quarterly tracking of the PC market in 1994. On March 28, data released by Gartner said worldwide IT spending is projected to increase 4.1% in 2013 to $3.8T. PRICE ACTION: Shares of Dell have slid more than 2.5% since the first day of trading following its Q4 report. Following the March announcement that Dell received alternative proposals from Blackstone and Icahn, shares closed as high as $14.51 per share. Through April, however, shares of Dell slipped, including a sharp decline after disclosing Blackstone withdrew its offer, with shares closing as low as $13.09 per share. In afternoon trading ahead of its Q1 report, shares of Dell are down 0.2%, to about $13.42. |
|
| 13:57 EDT | | DELL | Dell May 13 straddle priced for 1.7% move into Q1
Subscribe for More Information |
|
| 09:36 EDT | | NFLX | Active equity option families trading on open
Subscribe for More Information |
|
| 08:55 EDT | | MRK | BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information |
|
| May 15, 2013 |
| 17:21 EDT | | ELN | Elan publishes response document regarding Echo Pharma offer
Elan announces publication of a response document in respect of the Echo Pharma Acquisition Limited offer made on May 2. The response document is published in accordance with Rules 25 and 30.3 of the Irish Takeover Rules and the United States tender offer rules. As previously advised, the Board of Elan has unanimously, and without reservation, rejected the offer by Royalty Pharma. Shareholders are strongly advised to take no action in relation to the offer. |
|
| 16:48 EDT | | DELL | Icahn gives quarterly update on stakes
Subscribe for More Information |
|
| 16:02 EDT | | NFLX | Options Update; May 15, 2013
Subscribe for More Information |
|
| 14:56 EDT | | MCK | McKesson has a conference call hosted by JPMorgan
Subscribe for More Information |
|
| 14:28 EDT | | NFLX | Netflix targets 100 basis points of margin expansion a quarter
Subscribe for More Information |
|
| 12:17 EDT | | NFLX | Icahn paper profit in Netflix tops $1B, WSJ reports
Subscribe for More Information |
| |
| 10:51 EDT | | NFLX | Netflix CFO says growing subscribers at $8 price point
Subscribe for More Information |
|
| 10:42 EDT |  | NFLX | Netflix moves higher, levels to watch
The shares are moving against the broader sideways or down move in technology today, last at $244.10. It would appear that traders are intent on moving the shares back toward the $250 area. That area in the prior two-years was important support and then resistance. When the shares broke below that level in August 2011, it presaged a steep decline in share price. Retaking that level and holding it therefore might encourage more bullishness for higher price. A failure to do so could potentially derail the current trend higher. |
|
| 10:31 EDT | | NFLX | Netflix volatility at one year low as shares at 21-month high
Subscribe for More Information |
|
| 10:13 EDT | | NFLX | Netflix loved by consumers in survey, says BTIG
Subscribe for More Information |
|
| 09:43 EDT | | NFLX | Active equity option families trading on open
Subscribe for More Information |
|
| 09:01 EDT | | NFLX | Netflix EPS could reach $10+, says RBC Capital
Subscribe for More Information |
|
| 08:08 EDT | | DELL | PC sales decline in Western Europe, Economic Times reports
Subscribe for More Information |
|
| 07:26 EDT | | NFLX | Netflix ready for battle in Canada, Globe and Mail reports
Netflix may have won the initial battle for online viewers in Canada, but CEO Reed Hastings says it must now survive an onslaught from the country’s traditional TV companies, reports the Globe and Mail. Hastings said the company is prepared to aggressively bid for movie and TV rights while earmarking increasingly higher amounts to produce original content to entice viewers into cutting their cords. Reference Link |
|
| 06:55 EDT | | GDOT | Green Dot expects GoBank to be available by July 4
During its presentation at FinovateSpring yesterday, Green Dot's GoBank announced that it expects to be generally available by July 4. GoBank is the first bank account designed specifically for the mobile device, the company said. |
|
| May 14, 2013 |
| 17:39 EDT | | MRK | Moody's lowers Merck's guaranteed debt to A1 from Aa3; stable outlook
Moody's Investors Service lowered the long-term ratings of Merck by one notch, including the guaranteed senior unsecured rating to A1 from Aa3 and the non-guaranteed senior unsecured rating to A2 from A1. This action concludes a review for downgrade initiated on May 1, 2013. At the same time, Moody's affirmed Merck's Prime-1 commercial paper rating. The rating outlook is stable. |
| |
| 16:23 EDT | | DELL | On The Fly: Closing Wrap
Stocks on Wall Street were higher on a Tuesday again, keeping the strange "Tuesday in 2013" streak alive. Some positive domestic economic data and bullish commentary from Appaloosa Management's David Tepper set the tone early and the averages traded with an upward bias for almost the entire trading day. Today's advance means that every Tuesday this year has seen the market log gains, and investors will have to wait another week to see if the pattern continues. ECONOMIC EVENTS: The NFIB small business optimism index for April rose to 92.1, versus expectations for it to climb to 90.3 from its prior 89.5 reading. Import prices were reported to have declined 0.5% in April, which was in-line with expectations. Export prices declined 0.7%, versus a forecast for a 0.1% drop in the month. COMPANY NEWS: Dell (DELL) shares lost 6c, or 0.44%, to $13.46 after Dow Jones said the company will report first quarter non-GAAP earnings of 20c per share, 15c below current consensus estimates. That followed an earlier report from CNBC's David Faber, who also said the company will report earnings that miss expectations and accurately called that Dell has moved its report to Thursday, which is earlier than had been expected... Sony (SNE) shares added $1.87, or 9.9%, but closed off their best levels at $20.76 after the New York Times reported that Dan Loeb of Third Point has built a 6.5% stake and proposes that the company take its entertainment unit public. MAJOR MOVERS: Among notable gainers was InterOil (IOC), up $7.46, or 9.57%, to $85.39 after reporting its earnings and saying its talks with "major oil companies and a national oil company" about a potential LNG partnership are in the final stages. Also higher was SodaStream (SODA), up $6.79, or 11.85%, to $64.08 after at least two analyst firms raised their price target on shares following yesterday's analyst day presentations. Among noteworthy losers was Solar City (SCTY), down $4.44, or 12.37%, to $31.44 after the company's first quarter earnings missed expectations and the stock was downgraded by at least two firms. Also lower was Velti (VELT), down 29c, or 14.5%, to $1.71 after its revenue outlook fell below estimates. INDICES: The Dow was up 123.57, or 0.82%, to 15,215.25; the Nasdaq was up 23.82, or 0.69%, to 3,462.61; and the S&P 500 was up 16.57, or 1.01%, to 1,650.34. |
|
| 16:00 EDT | | NFLX | Options Update; May 14, 2013
Subscribe for More Information |
|
| 13:18 EDT | | DELL | Dell to report Q1 non-GAAP EPS 20c, Dow Jones says
Subscribe for More Information |
|
| 12:35 EDT | | DELL | Dell holder Pzena prefers Icahn, Southeastern proposal, CNBC reports
Cites statement from Rich Pzena, who called the Icahn and Southeastern proposal "superior" to the "go-private" deal supported by founder Michael Dell. |
|
| 11:18 EDT | | DELL | Dell earnings to miss consensus expectations, CNBC reports
Subscribe for More Information |
|
| 11:17 EDT | | DELL | Dell May volatility increases into Q1 and revenue outlook
Dell May call option implied volatility is at 33, June and July is at 14; compared to its 14-week average of 16 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on May 16. |
|
| 11:13 EDT | | DELL | Dell moving up earnings announcement to Thursday, CNBC reports
Subscribe for More Information |
|
| 11:12 EDT | | DELL | Dell earnings expected to be below consensus, CNBC reports
|
|
| 10:49 EDT | | DELL | Dell accuses optical disk drive makers of price-fixing, Bloomberg says
Subscribe for More Information |
|
| 10:01 EDT |  | VVUS | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital. |
| |
| 09:54 EDT | | NFLX | Netflix rebound continues, levels to watch
Subscribe for More Information |
|
| 09:38 EDT | | NFLX | Active equity option families trading on open
Subscribe for More Information |
|
| 08:19 EDT | | DELL | David Tepper says Dell in tough business, no position in company
|
|
| 07:33 EDT | | VVUS | VIVUS downgraded to Neutral from Buy at Lazard Capital
Subscribe for More Information |
|
| 07:15 EDT | | TSN | BMO Capital to host a conference
Subscribe for More Information |
|
| 07:07 EDT | | ELN | Theravance price target raised to $54 from $44 at Stifel
Stifel thinks that Theravance's (THRX) royalty deal with Elan (ELN) demonstrates its ability to generate revenue that had not been reflected in its stock price. The firm expects Theravance to make similar deals in the future and it keeps a Buy rating on the stock. |
|
| 07:05 EDT | | NFLX | Netflix continues to lead web usage in North America, AllThingsD reports
Subscribe for More Information |
|
| 05:44 EDT | | DELL | Banks work deals from both sides of the field, WSJ reports
Subscribe for More Information |
|
| May 13, 2013 |
| 16:49 EDT | | DELL | Icahn, Southeastern to nominate several parties to Dell board
Subscribe for More Information |
|
| 16:25 EDT | | DELL, ELN | On The Fly: Closing Wrap
Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. |
| |
| 15:45 EDT | | NFLX | Options Update; May 13, 2013
Subscribe for More Information |
|
| 12:20 EDT | | ELN, DELL | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 12:06 EDT | | NFLX | Stocks with call strike movement; CLF NFLX
Subscribe for More Information |
|
| 10:09 EDT | | CTRP | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 09:37 EDT | | LTM | Kalmar reports 5.12% passive stake in Life Time Fitness
Subscribe for More Information |
|
| 09:25 EDT | | ELN | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 07:41 EDT | | VVUS | VIVUS mails letter to stockholders providing business update
Subscribe for More Information |
|
| 07:22 EDT | | DELL | Dell special committee asks for more info from Icahn, Southeastern Asset
Subscribe for More Information |
|
| 07:17 EDT | | DELL | Dell special committee asks for more info from Icahn, Southeastern Asset
|
|
| 06:00 EDT | | CTRP | Ctrip.com downgraded to Neutral from Buy at Goldman
Subscribe for More Information |
| |
| 05:44 EDT | | ELN | Elan provides additional information on Elan/Theravance agreement
Subscribe for More Information |
|
| 05:35 EDT | | ELN | Theravance, Elan enter into $1B royalty participation agreement
Subscribe for More Information |
|
| 05:31 EDT | | ELN | Theravance, Elan enter into $1B royalty participation agreement
|
|
| 05:26 EDT | | ELN | Theravance to host conference call
Subscribe for More Information |
|
| May 12, 2013 |
| 18:35 EDT | | DELL | Carl Icahn's newest offer could be better deal for Dell holders, Barron's says
Subscribe for More Information |
|
| May 10, 2013 |
| 16:29 EDT | | DELL | On The Fly: Closing Wrap
Subscribe for More Information |
|
| 13:07 EDT | | DELL | Dell committee says 'carefully reviewing' Icahn, Southeastern proposal
Dell's Special Committee issued a statement regarding a proposal it has received from Carl Icahn and Southeastern Asset Management. The statement read: "Mr. Icahn and Southeastern have outlined a potential leveraged recapitalization transaction that they want the Dell Board either to recommend at this time or to consider if the existing going-private transaction is rejected by Dell shareholders. They have also proposed replacing the Board with a slate of new directors who they say would approve such a transaction. Consistent with the Special Committee’s goal of achieving the best possible outcome for all shareholders, we and our advisors are carefully reviewing the potential transaction to assess the potential risks and rewards to the public shareholders." |
|
| 13:05 EDT | | DELL | Dell committee says 'carefully reviewing' Icahn transaction
Subscribe for More Information |
|
| 12:54 EDT | | NFLX | Icahn says 'we haven't sold a share' of Netflix
Subscribe for More Information |
|
| 12:51 EDT | | DELL | Carl Icahn: 'I've made fortunes going against Jim Chanos'
Subscribe for More Information |
| |
| 12:47 EDT | | DELL | Icahn says if board is elected, Michael Dell won't run Dell
Subscribe for More Information |
|
| 12:46 EDT | | DELL | Icahn says would personally put up over $2B for Dell bridge loan if needed
Carl Icahn is speaking on CNBC. |
|
| 12:42 EDT | | DELL | Icahn says 'not looking to make a dollar' on Dell shares
Carl Icahn is speaking on CNBC. |
|
| 12:39 EDT | | DELL | Icahn says proposing full slate of 12 Dell board members on Monday
Carl Icahn is speaking on CNBC. |
|
| 12:37 EDT | | DELL | Icahn says Dell needs change in culture
Carl Icahn is speaking on CNBC. |
|
| 12:31 EDT | | DELL | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 12:11 EDT | | TSN | U.S. red meat, poultry production seen higher than year ago
Subscribe for More Information |
|
| 11:48 EDT | | MRK | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 11:47 EDT | | NFLX | Stocks with call strike movement; TSO NFLX
Subscribe for More Information |
|
| 09:38 EDT | | NFLX | Active equity option families trading
Subscribe for More Information |
| |
| 06:53 EDT | | MRK | GlaxoSmithKline, Merck to discount cancer vaccine in poor nations, NY Times says
Subscribe for More Information |
|
| 06:15 EDT | | DELL | Icahn reports 4.52% stake in Dell, sends buyout proposal to board
Carl Icahn disclosed a 4.52% stake in Dell as well a letter sent to the company's board offering an alternative buyout proposal. The letter stated in part, "We are a group of Dell Inc. shareholders that own in the aggregate approximately 13% of the outstanding shares of Dell Inc. From the announcement of the Agreement and Plan of Merger, dated as of February 5, 2013 we have stated repeatedly that we believe that the Going Private Transaction is not in the best interests of Dell shareholders and substantially undervalues the company. As a result, we will vote against the Going Private Transaction." The group's proposal gives shareholders the right to continue as owners and keep their existing equity position in Dell. The shareholders would also be given the opportunity to elect to receive a distribution of $12 per share in cash or $12 in additional shares valued at $1.65 per share. Icahn and Southeastern said they would both elect to receive additional shares rather than cash. Both investors said financing for their proposal would be obtained from Dell's existing cash and $5.2B in new debt. Icahn and Southeastern believe their proposal is superior to Dell's going private transaction. |
|
| 06:08 EDT | | DELL | Carl Icahn discloses 4.52% stake in Dell, proposal letter to board
Subscribe for More Information |
|
| 06:03 EDT | | DELL | Icahn, Southeastern propose alternative buyout for Dell, WSJ reports
Subscribe for More Information |
|
| May 9, 2013 |
| 11:15 EDT | | NFLX | Netflix up 2% to $212.82 after reaching deal with Disney for TV shows
Subscribe for More Information |
|
| 11:02 EDT | | NFLX | Netflix and Disney announce multi-year licensing deal for XD shows
Subscribe for More Information |
|
| 10:08 EDT | | CTRP | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:54 EDT | | CTRP | Ctrip.com gaps up sharply following earnings beat, levels to watch
Subscribe for More Information |
|
| 09:00 EDT | | CTRP | Ctrip.com rises 17%
Subscribe for More Information |
|
| 08:51 EDT | | MCK | Humana appoints Roy A. Beveridge, M.D., as Chief Medical Officer
Humana (HUM) has appointed Roy A. Beveridge, M.D. as Senior VP and Chief Medical Officer, effective June 17. Dr. Beveridge is currently Chief Medical Officer for McKesson Specialty Health, a subsidiary of McKesson (MCK). |
| |
| 08:37 EDT | | CTRP | Ctrip.com price target raised to $34 from $25 at Brean Capital
Brean Capital raised its price target on Ctrip.com following better than expected Q4 results. The firm believes it is an attractive name for investors looking to be involved in secular leisure and online travel growth in China. Shares are Buy rated. |
|
| 08:14 EDT | | CTRP | Ctrip.com upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded Ctrip followign the better than expected Q1 report. |
|
| 08:13 EDT | | CTRP | Ctrip.com upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information |
|
| 08:05 EDT | | CTRP | Ctrip.com upgraded to Buy from Outperform at CLSA
CLSA upgraded Ctrip.com due to the strong Q1 report, top line growth, and higher operating leverage. Price target is $31. |
|
| 07:22 EDT | | MRK | Merck awarded significant portion of UNICEF HPV vaccine tender
Subscribe for More Information |
|
| 05:54 EDT | | DELL | Stocks with implied volatility movement; DELL BAX
Subscribe for More Information |
|
| May 8, 2013 |
| 18:04 EDT | | CTRP | Ctrip.com sees Q2 net revenue growth approximately 15%-20% over last year
Subscribe for More Information |
|
| 18:02 EDT | | CTRP | Ctrip.com reports Q1 adjusted EPS 30c, consensus 12c
Reports Q1 revenue $187M, consensus $172.63M. |
|
| 10:27 EDT | | NFLX | Hertz, Spark Networks among Tilson's new picks, Business Insider says
Hedge fund manager Whitney Tilson gave two new stock picks-- Hertz (HTZ) and Spark Networks (LOV)-- at the Value Investing Congress in Las Vegas this week and also gave an update on some of his other favorites, including AIG (AIG), Berkshire Hathaway (BRK.A) and Netflix (NFLX), reported Business Insider. Reference Link |
|
| 09:51 EDT | | ADNC | Audience CFO Palatnik buys 25K shares
Subscribe for More Information |
| |
| 08:32 EDT | | MRK | Merck says FDA accepts biologics license application for allergy tablet
Merck announced that the Biologics License Application for its investigational ragweed pollen sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration. The BLA for Merck’s investigational ragweed pollen sublingual allergy immunotherapy tablet is supported by five studies evaluating the efficacy and safety of the tablet in adults, 18 years of age or older, with ragweed induced allergic rhinitis. On March 27, Merck announced that the FDA had also accepted the BLA for its investigational Timothy grass pollen sublingual allergy immunotherapy tablet. Merck expects the FDA’s review for both to be completed in the first half of 2014. |
|
| 07:35 EDT | | VVUS | VIVUS reports Q1 EPS (53c), consensus (51c)
Reports Q1 revenue $4.11M, consensus $5.22M. |
|
| 07:23 EDT | | NFLX | Rogers Communications to battle Netflix, Globe and Mail reports
Subscribe for More Information |
|
|
|
|
|
